A federal agency granted $4.8 million to continue developing a vaccine that has shown promising results in preventing valley fever among dogs and could lead to a breakthrough for humans, Dr. John Galgiani, one of the nation’s leading valley fever researchers, said during a rare visit to Bakersfield Tuesday.